Company Overview

KMC Speciality Hospitals operates a 450-bed Multi-Specialty Hospital in Trichy, Tamil Nadu, comprising a legacy block of 250 beds and a new block of 200 beds focused on Mother and Child Care services operational since January 29, 2024. Key specialties include Mother & Child Care Services, Neurosciences, Gastro Sciences, Orthopedics, Plastic surgeries, Organ Transplants (Liver & Bone Marrow Transplant), and Critical care.

The hospital has over 1,700 full-time employees and associates including 170 doctors. Approximately 89% of in-patient revenue comes from cities in and around Tiruchirapalli.

The company is a 75% owned subsidiary of Sri Kauvery Medical Care (India) Limited ("The Group"), which operates 12 Multi-Speciality Hospitals with over 2,574 beds across Chennai, Trichy, Bengaluru, Salem, Hosur and Tirunelveli.

Q1 FY2027 Financial Performance

Income Statement Highlights:

  • Revenue from operations: ₹305.8 Cr (32.0% YoY increase from ₹231.6 Cr in Q1 FY26)
  • Other Income: ₹5.1 Cr (64.5% YoY increase from ₹3.1 Cr)
  • Total Income: ₹310.8 Cr (32.5% YoY increase from ₹234.7 Cr)
  • Cost of materials consumed: ₹14.6 Cr (47.7% YoY increase)
  • Purchase of traded goods: ₹30.6 Cr (24.8% YoY increase)
  • Employee benefits expense: ₹65.8 Cr (26.8% YoY increase)
  • Other Expenses: ₹107.0 Cr (20.0% YoY increase)
  • EBITDA: ₹93.0 Cr (55.1% YoY increase from ₹60.0 Cr)
  • EBITDA Margin: 29.9% (improved from 25.6% in Q1 FY26)
  • Finance costs: ₹8.3 Cr (11.8% YoY decrease)
  • Depreciation and amortization: ₹21.7 Cr (14.3% YoY increase)
  • Profit Before Tax (PBT): ₹63.0 Cr (99.4% YoY increase from ₹31.6 Cr)
  • PBT Margin: 20.3% (improved from 13.5%)
  • Income tax expense: ₹16.3 Cr (60.1% YoY increase)
  • Profit After Tax (PAT): ₹46.7 Cr (118.1% YoY increase from ₹21.4 Cr)
  • PAT Margin: 15.0% (improved from 9.1%)

Balance Sheet Position (as of June 30, 2026):

  • Total Equity: ₹226.84 Cr
  • Share Capital: ₹16.31 Cr
  • Other Equity: ₹210.53 Cr
  • Non-Current Liabilities: ₹78.23 Cr
  • Borrowings: ₹58.70 Cr
  • Lease Liabilities: ₹10.10 Cr
  • Deferred Tax Liabilities: ₹2.96 Cr
  • Provisions: ₹6.10 Cr
  • Current Liabilities: ₹55.31 Cr
  • Borrowings: ₹9.60 Cr
  • Lease Liabilities: ₹4.42 Cr
  • Trade payables: ₹16.78 Cr
  • Current Tax Liabilities (net): ₹8.68 Cr
  • Total Assets: ₹360.38 Cr
  • Non-Current Assets: ₹250.75 Cr
  • Property, Plant and Equipment: ₹230.48 Cr
  • Right-of-Use-Assets: ₹14.40 Cr
  • CWIP: ₹1.57 Cr
  • Current Assets: ₹109.63 Cr
  • Cash and cash equivalents: ₹69.49 Cr
  • Bank balances other than above: ₹4.95 Cr
  • Total Cash Balance (including Fixed Deposit): ₹81.2 Cr (compared to ₹60.8 Cr as of March 31, 2026)

Cash Flow Statement (Q1 FY27):

  • Net Cash from Operating Activities: ₹79.10 Cr
  • Net Cash from Investing Activities: ₹(16.93) Cr
  • Net Cash from Financing Activities: ₹(21.34) Cr
  • Net Increase in Cash and Cash Equivalents: ₹40.83 Cr

Financial Ratios:

  • Return on Capital Employed: 33%
  • Return on Equity: 29%
  • Debt Equity Ratio: 0.30
  • Current Ratio: 2.0 times
  • DSCR: 11.1 times
  • Interest Coverage Ratio: 15.1 times
  • Net Debt/EBITDA: Negative (cash exceeds debt)

Operational Performance

Q1 FY27 Key Metrics:

  • Census Beds: 330 (0% YoY change)
  • Occupied Beds: 283 (25% YoY increase from 227)
  • Average Occupied Bed Days: 25,723 (25% YoY increase)
  • Average Occupancy Rate: 86% (from 69% in Q1 FY26)
  • Average Length of Stay (ALOS): 5.0 days (0% YoY change)
  • In-Patient Volumes: 5,168 (25% YoY increase from 4,149)
  • Out-Patient Volumes: 55,684 (31% YoY increase from 42,573)
  • Blended ARPOB: ₹34,214 (11% YoY increase from ₹30,849)
  • ARPP IP: ₹139,218 (10% YoY increase from ₹126,049)
  • ARPP OP: ₹2,884 (8% YoY increase from ₹2,673)

Revenue Mix:

The presentation notes consistent strong performance of 26% on Total Income in Q1 FY27 from Mother and Child Care services.

Historical Performance Context

The investor presentation includes historical financial and operational data from FY22 to FY26 showing consistent growth:

  • Total Income grew from ₹138.2 Cr in FY22 to ₹310.8 Cr in FY26
  • PAT increased from ₹23.7 Cr in FY22 to ₹46.7 Cr in FY26
  • Occupancy rates improved from 79% in FY22 to 76% in FY26
  • Blended ARPOB increased from ₹22,887 in FY22 to ₹32,085 in FY26

Leadership and Governance

The document highlights the leadership team including:

  • Dr. S. Chandrakumar - Founder & Executive Chairman
  • Dr. S. Manivannan - Founder & Managing Director
  • Dr. D. Senguttuvan - SBU Head, Executive Director & Key Managerial Person

The Board of Directors includes 8 members with representation from medical professionals and independent directors.

Strategic Focus Areas

The company's sustainable growth strategy emphasizes:

  • Cutting Edge Technology adoption
  • Doctors Engagement Model for talent retention
  • Capacity Expansion (450 total beds across two blocks)
  • Centers of Excellence focus
  • Quality/Digital Enablement (NABH accreditation, 5S methodology)